Ubs Group Ag Albireo Pharma, Inc. Transaction History

Ubs Group Ag

  • $400 Billion
  • Q2 2024

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 08, 2023
BUY
$18.01 - $23.78 $97,235 - $128,388
5,399 Added 705.75%
6,164 $133,000
Q3 2022

Nov 10, 2022
BUY
$16.32 - $26.37 $5,858 - $9,466
359 Added 88.42%
765 $15,000
Q2 2022

Aug 10, 2022
SELL
$18.54 - $37.29 $758,137 - $1.52 Million
-40,892 Reduced 99.02%
406 $8,000
Q1 2022

May 16, 2022
BUY
$23.94 - $33.74 $617,556 - $870,357
25,796 Added 166.4%
41,298 $1.23 Million
Q4 2021

Feb 14, 2022
BUY
$21.19 - $31.29 $315,349 - $465,657
14,882 Added 2400.32%
15,502 $361,000
Q3 2021

Nov 15, 2021
BUY
$27.36 - $35.98 $547 - $719
20 Added 3.33%
620 $19,000
Q2 2021

Aug 13, 2021
SELL
$28.9 - $36.87 $791,888 - $1.01 Million
-27,401 Reduced 97.86%
600 $21,000
Q1 2021

May 12, 2021
BUY
$32.03 - $42.85 $893,989 - $1.2 Million
27,911 Added 31012.22%
28,001 $987,000
Q4 2020

Feb 11, 2021
SELL
$31.56 - $42.16 $164,553 - $219,822
-5,214 Reduced 98.3%
90 $3,000
Q3 2020

Nov 12, 2020
BUY
$23.19 - $41.61 $23,932 - $42,941
1,032 Added 24.16%
5,304 $177,000
Q2 2020

Jul 31, 2020
SELL
$14.82 - $29.92 $45,838 - $92,542
-3,093 Reduced 42.0%
4,272 $113,000
Q1 2020

May 01, 2020
SELL
$11.67 - $27.23 $105,520 - $246,213
-9,042 Reduced 55.11%
7,365 $121,000
Q4 2019

Feb 14, 2020
BUY
$16.92 - $28.96 $109,049 - $186,647
6,445 Added 64.7%
16,407 $417,000
Q3 2019

Nov 14, 2019
BUY
$20.0 - $31.88 $141,860 - $226,124
7,093 Added 247.23%
9,962 $199,000
Q2 2019

Aug 14, 2019
BUY
$30.67 - $37.86 $87,225 - $107,673
2,844 Added 11376.0%
2,869 $93,000
Q1 2019

May 14, 2019
SELL
$22.22 - $32.21 $73,970 - $107,227
-3,329 Reduced 99.25%
25 $1,000
Q4 2018

Feb 14, 2019
SELL
$20.9 - $32.57 $233,055 - $363,188
-11,151 Reduced 76.88%
3,354 $82,000
Q3 2018

Nov 14, 2018
BUY
$29.29 - $36.87 $96,276 - $121,191
3,287 Added 29.3%
14,505 $478,000
Q2 2018

Aug 14, 2018
BUY
$28.9 - $37.31 $60,025 - $77,492
2,077 Added 22.72%
11,218 $398,000
Q4 2017

Feb 14, 2018
BUY
$21.56 - $28.14 $197,079 - $257,227
9,141 New
9,141 $234,000
Q3 2017

Nov 14, 2017
SELL
$20.44 - $25.65 $20 - $25
-1 Closed
0 $0
Q2 2017

Aug 14, 2017
SELL
N/A
-244 Reduced 99.59%
1 $0
Q1 2017

Nov 14, 2017
BUY
N/A
245
245 $6,000

Others Institutions Holding ALBO

# of Institutions
4
Shares Held
865
Call Options Held
0
Put Options Held
0
View Full List

About ALBIREO PHARMA, INC.

ALBO Quotes by TradingView
  • Ticker ALBO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 19,612,500
  • Description
  • Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...
More about ALBO
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email